By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Knopp NeuroSciences 

100 Technology Drive
Suite 440
Pittsburgh  Pennsylvania  15219  U.S.A.
Phone: n/a Fax:



Start Up

Company News
Biogen Idec, Inc. (Massachusetts) (BIIB) Asked in Suit to Return ALS Biosamples to Knopp NeuroSciences 3/11/2013 8:42:01 AM
Knopp NeuroSciences Forms New Parent Company, Knopp Biosciences to Expand Operations and Mission 10/14/2010 7:33:53 AM
Biogen, Inc. Buys License to Late-Stage Nerve Disease Pill From Knopp NeuroSciences for $345 Million 8/18/2010 7:13:46 AM
Knopp NeuroSciences Presents Further Encouraging Trends in Its Phase 2 Study of KNS-760704 (Dexpramipexole) in ALS 4/16/2010 11:38:56 AM
Knopp NeuroSciences Reports Presentation of Encouraging Clinical Trends in a Phase 2 Study of KNS-760704 in ALS 12/9/2009 9:41:20 AM
Knopp NeuroSciences Receives FDA Fast Track Designation for KNS-760704 in ALS 9/2/2009 10:19:30 AM
Knopp NeuroSciences to Present Phase 2 Results of KNS-760704 in ALS 8/11/2009 10:10:53 AM
European Commission Awards Orphan Designation to Knopp NeuroSciences' KNS-760704 in ALS 3/10/2009 9:17:00 AM
Knopp NeuroSciences Completes Series B2 Financing, Raising Total Capitalization to $27 Million 11/19/2008 6:20:40 AM
Knopp NeuroSciences Initiates Phase 2 Study of KNS-760704 in Amyotrophic Lateral Sclerosis 4/7/2008 9:15:39 AM